The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2008

Filed:

Dec. 04, 2003
Applicants:

Yuki Endo, Tsukuba, JP;

Hideki Endoh, Tsukuba, JP;

Yoshitaka Ueda, Tsukuba, JP;

Miyuki Kato, Tsukuba, JP;

Kazunori Inabe, Tsukuba, JP;

Inventors:

Yuki Endo, Tsukuba, JP;

Hideki Endoh, Tsukuba, JP;

Yoshitaka Ueda, Tsukuba, JP;

Miyuki Kato, Tsukuba, JP;

Kazunori Inabe, Tsukuba, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12N 15/63 (2006.01); C12N 15/85 (2006.01); C12N 15/86 (2006.01); C12N 1/21 (2006.01); C12N 5/14 (2006.01); C12N 1/20 (2006.01); C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel polypeptide, a polynucleotide, an expression vector, a cell transfected with the expression vector, a method for screening an insulin resistance improving agent and a carbohydrate metabolism improving agent, and a method for producing a pharmaceutical composition are provided. The polypeptide is useful in screening an insulin resistance improving agent and a carbohydrate metabolism improving agent. When the polypeptide is overexpressed in a fat cell, the activity of Akt2 is reduced. Fat cells express the polypeptide. The polynucleotide encodes the polypeptide. The expression vector includes the polynucleotide. The screening method uses the polypeptide to screen for an insulin resistance improving agent and a carbohydrate metabolism improving agent. The production method uses the substance obtained by the screening method as the active ingredient of the pharmaceutical composition. The pharmaceutical composition is useful for insulin resistance improvement and carbohydrate metabolism improvement.


Find Patent Forward Citations

Loading…